Skip to content
Search

Latest Stories

Community Pharmacy England unveils future strategy and workplan: Watch the presentation on-demand

Community Pharmacy England unveils future strategy and workplan: Watch the presentation on-demand

Additionally, Community Pharmacy England has outlined its plans to engage with and influence the new government  

Community Pharmacy England (CPE) has released a recorded presentation outlining its strategy for improving the future of community pharmacies, now available to watch on-demand.

The presentation highlights key issues facing the sector and details the organisation’s plans to support pharmacy owners and their teams.


The presentation comes at a pivotal time, following the conclusion of the five-year Community Pharmacy Contractual Framework (CPCF) and the recent General Election.

Recognising these moments as critical junctures for the future of the sector, CPE has been actively developing strategies to secure a more sustainable future for community pharmacies.

CPE Chief Executive Janet Morrison, along with her team and Committee Members, conducted a series of in-person roadshows across all regions outside of London in July, informing pharmacy owners and their representatives about their ongoing work to tackle key issues and plans for the future.

The on-demand presentation, originally livestreamed from one of these regional meetings, offers an in-depth overview of these strategies.

It provides detailed insights into community pharmacies' pressures, ongoing CPCF negotiations, Pharmacy First service, and the broader strategy of Community Pharmacy England to improve the outlook for pharmacy owners and their teams.

Additionally, Community Pharmacy England has outlined its plans to engage with and influence the new government. Key initiatives include:

  • Collaborating with PA Consulting to enhance their negotiating approach, evaluate NHS policy priorities and service opportunities, and deliver training to the Committee.
  • Undertaking an economic project to look at base case funding, cost-benefit analysis of the value delivered, and the business case for future investment in the community pharmacy sector.
  • Establishing contact with the majority of MPs and planning for their first Parliamentary event scheduled for the autumn.
  • Preparing a submission to Lord Darzi’s review of the state of the NHS, commissioned by the Health Secretary.
  • Planning for national media coverage to highlight the sector’s plight and the impact on patients.
  • Continuing dialogue with think tanks, patient groups and wider stakeholders to build wider support for community pharmacy.

Further details of CPE’s strategy and workplan for the current year were released in a briefing last week.

The 24 workplan for Community Pharmacy England includes:

  1. Delivering an improved Contractual Framework to address the current funding crisis and secure a stable future
  2. Driving the success of the Pharmacy First service, blood pressure and contraception services to demonstrate their value and the potential for a greater role for community pharmacy in clinical services.
  3. Promoting the role of community pharmacy as a vital part of an integrated primary care system and as hubs for community health.
  4. Building the investment case for further expansion of clinical services that can be developed into major service interventions.
  5. Guiding future developments in funding, policy and regulatory policies to enable community pharmacies to deliver services effectively and sustainably and respond to changing Governmental/NHS England priorities.
  6. Enhancing support for the community pharmacy sector through communications and engagement, working closely with the LPC network and driving standards of governance, accountability and transparency.

The CPE noted that the sector is currently confronting significant challenges, including consolidations, cashflow crises, closures, increasing instability in medicine supply and delivery of margin, a punishing workforce market and rising costs of

leases and cost of capital, energy and other supplies.

"The state of the community pharmacy sector has reached a critical point after years of systematic cuts and worsening economic conditions, coupled with rising demand and rising NHS expectations for delivery and efficiency," CPE writes in its briefing.

The CPE will be organising the final event in the roadshow series on 26 September in London.

CPE also plans to maintain continuous engagement with pharmacy owners throughout the year, using regular polling and participating in various sector conferences, including the Pharmacy Show.

To gain a deeper understanding of CPE's strategic vision for the future, watch the recorded presentation here.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less